Ferring Pharmaceuticals, Inc. Adopts Local Morristown Playground
5/15/2013 8:51:27 AM
More...
|
Ferring Pharmaceuticals Data Suggest Lower Risk of Cardiovascular Events or Deaths in Prostate Cancer Patients Treated With Degarelix Compared to LHRH Agonists
3/18/2013 10:46:41 AM
More...
|
Ferring Pharmaceuticals, Inc. Announces Launch of Heart to Heart Video Contest
3/5/2013 1:14:14 PM
More...
|
Ferring Pharmaceuticals, Inc. Release: In Patients With Active, Left-Sided Ulcerative Colitis, Study Shows Once-Daily Dose of Mesalazine Granules Provided Similar Results to Twice-Daily Dose
2/14/2013 9:43:45 AM
More...
|
Ferring Pharmaceuticals, Inc. Acquires Licensing Rights for Elobixibat from Albireo
7/3/2012 9:38:07 AM
More...
|
Ferring Pharmaceuticals, Inc. Release: FIRMAGON® (degarelix) Demonstrates Non-inferiority to goserelin with bicalutamide in Reducing Prostate Volume in Prostate Cancer Patients while Providing Better Relief from Lower Urinary Tract Symptoms
2/28/2012 7:02:47 AM
More...
|
OctoPlus Enters Into Drug Development and Manufacturing Contract With Ferring Pharmaceuticals A/S
2/2/2012 9:44:49 AM
More...
|
Ferring Pharmaceuticals, Inc. to Develop Major Corporate Center in Parsippany, New Jersey
11/21/2011 11:35:54 AM
More...
|
Ferring Pharmaceuticals, Inc. Release: New Data on Long-Term Use of FIRMAGON(R) (degarelix for injection) for Advanced Hormone-Dependant Prostate Cancer Published in Journal of Urology
9/1/2011 1:25:53 PM
More...
|
Ferring Pharmaceuticals, Inc. Congratulates R&B and Pop Icon Gloria Gaynor, Named 'Woman of the Year' by Arthritis Foundation
3/11/2011 10:32:05 AM
More...
|
|